1
|
Mulkerrin P, O'Shea F, Fitzgerald G. Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis. Osteoporos Int 2024; 35:929-930. [PMID: 38189929 DOI: 10.1007/s00198-023-07010-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Accepted: 12/21/2023] [Indexed: 01/09/2024]
Affiliation(s)
| | - Finbar O'Shea
- Department of Rheumatology, St. James' Hospital, Dublin, Ireland
- School of Medicine, Trinity College, Dublin, Ireland
| | - Gillian Fitzgerald
- Department of Medicine, University of Galway, Galway, Ireland
- Department of Rheumatology, Galway University Hospital, Galway, Ireland
| |
Collapse
|
2
|
Quinn S, Maguire S, O'Shea F, O'Neill L, Molloy E, Fearon U, Gallagher P, Veale DJ. Characteristics and burden of disease in patients with radiographic versus non-radiographic axial spondyloarthritis in the ASRI cohort. Ir J Med Sci 2024; 193:443-448. [PMID: 37418106 DOI: 10.1007/s11845-023-03439-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 06/26/2023] [Indexed: 07/08/2023]
Abstract
BACKGROUND Axial spondyloarthritis (axSpA) comprises patients with both radiographic and non-radiographic features. Previous studies have shown similar burden of disease between these two groups. AIMS The Ankylosing Spondylitis Registry of Ireland (ASRI) was formed with the objective to measure the burden of axial spondyloarthritis in the population and identify early predictors of a poor outcome. For this analysis, the ASRI database was used to compare the characteristics and burden of disease in patients with radiographic versus non-radiographic axial spondyloarthritis. METHODS Patients with radiographic axial spondyloarthritis (r-axSpA) were defined as those with X-ray evidence of sacroiliitis. Patients with non-radiographic axial spondyloarthritis (nr-axSpA) were defined as having MRI evidence of sacroiliitis but no X-ray evidence of sacroiliitis. RESULTS In total, 764 patients were included. Analysis of radiographic status showed 88.1% (n = 673) of patients with r-axSpA and 11.9% (n = 91) with nr-axSpA (Table 1). Patients with nr-axSpA were younger (41.3 vs. 46.6 years, p < 0.01), had shorter disease duration (14.8 vs. 20.2 years, p < 0.01) and had lower proportion of males (66.6% vs. 78.4%, p = 0.02) with lower frequency of HLA-B27 positivity (73.6% vs. 90.5%, p < 0.01). The nr-axSpA group had lower BASDAI (3.37 vs. 4.05, p = 0.01), BASFI (2.46 vs. 3.88, p < 0.01), BASMI (2.33 vs. 4.34, p < 0.01), ASQoL (5.2 vs. 6.67, p = 0.02) and HAQ scores (0.38 vs. 0.57, p < 0.01). There were no significant differences in the prevalence of extra-musculoskeletal manifestations or use of medications. CONCLUSIONS This study provides evidence to suggest that the burden of disease is less in patients with non-radiographic axial spondyloarthritis than radiographic axial spondyloarthritis.
Collapse
Affiliation(s)
- Sean Quinn
- Rheumatology Department, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
| | - Sinead Maguire
- Rheumatology Department, St James' Hospital, Dublin 8, Ireland
| | - Finbar O'Shea
- Rheumatology Department, St James' Hospital, Dublin 8, Ireland
| | - Lorraine O'Neill
- Rheumatology Department, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland
| | - Eamonn Molloy
- Rheumatology Department, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland
| | - Ursula Fearon
- Molecular Rheumatology, Trinity Biomedical Sciences Institute, Pearse St., Dublin 2, Ireland
| | - Phil Gallagher
- Rheumatology Department, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland
| | - Douglas J Veale
- The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Elm Park and University College Dublin, Dublin 4, Ireland
| |
Collapse
|
3
|
O'Farrell R, Maguire S, Moore L, Murray K, Gorman A, Ball E, Riddell C, O'Neill M, Jordan N, O'Shea F, Veale D, Donnelly S, Murphy G, Fitzgerald G. Delivering Care for Pregnant Women with Rheumatic and Musculoskeletal Diseases. Ir Med J 2024; 117:894. [PMID: 38259237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/24/2024]
|
4
|
Dinneen B, O'Shea F. The Lingering Health Challenge: Addressing Obesity in Axial Spondyloarthritis. J Rheumatol 2023:jrheum.2023-0744. [PMID: 37778760 DOI: 10.3899/jrheum.2023-0744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/03/2023]
Abstract
Axial spondyloarthritis (axSpA) is a chronic inflammatory disorder that primarily affects the axial skeleton, including the spine and sacroiliac joints.1 It encompasses both nonradiographic axSpA (nr-axSpA) and radiographic axSpA (also known as ankylosing spondylitis [AS]), the latter characterized by radiographic evidence of sacroiliitis.2.
Collapse
Affiliation(s)
- Brona Dinneen
- B. Dinneen, MRCPI, Department of Rheumatology, St. James's Hospital
| | - Finbar O'Shea
- F. O'Shea, MB BCh BAO, Department of Rheumatology, St. James's Hospital, and School of Medicine, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
5
|
Abstract
"Disease modification" in axial spondyloarthritis (axSpA) seeks to not only alleviate clinical symptoms but also alter the disease's natural course by impeding new bone formation. Recent years have witnessed the effectiveness of treatments, including biologics and nonsteroidal anti-inflammatory drugs, in managing axSpA symptoms. Emerging evidence points toward their potential impact on slowing structural disease progression. This comprehensive review centers on the pivotal role of inhibiting new bone formation in axSpA disease modification. It delves into the significance of imaging techniques for assessing disease progression and explores the disease-modifying properties of available axSpA treatments, encompassing NSAIDs, TNF inhibitors, IL-17 inhibitors, and JAK inhibitors. This article offers valuable insights into the evolving landscape of disease modification strategies in axial spondyloarthritis, highlighting the multifaceted approaches used to attain these objectives.
Collapse
Affiliation(s)
- Brona Dinneen
- Department of Rheumatology, St James's Hospital, Dublin, Ireland.
| | - Finbar O'Shea
- Department of Rheumatology, St James's Hospital, Dublin, Ireland; School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - Lianne Gensler
- Department of Rheumatology, University of California, San. Francisco (UCSF) Medical Centre, California, United States
| |
Collapse
|
6
|
Karkon S, O'Shea F, Doran M, McCormack H, Connolly D. Testing the feasibility and acceptability of an online 'Fatigue and Activity Management Education for Work (FAME-W) programme' for individuals with inflammatory arthritis. Musculoskeletal Care 2023; 21:815-826. [PMID: 36929565 DOI: 10.1002/msc.1756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Revised: 02/22/2023] [Accepted: 02/25/2023] [Indexed: 03/18/2023]
Abstract
INTRODUCTION Fatigue and Activity Management Education for Work (FAME-W) is a four-week, occupational therapy led programme focussing on fatigue management strategies. FAME-W was designed to be delivered in person; however, due to COVID-19 pandemic it was modified to be an online group-based self-management intervention. The purpose of this study was to test the feasibility and acceptability of the online delivery format of FAME-W. METHODS This was a mixed methods study. Participants were randomly allocated to intervention or control group. Participants in the intervention group received a four-week online FAME-W. The control group participants received a FAME-W handbook. Participants were required to complete questionnaires on work presenteeism, fatigue, mood, Health Related Quality of Life and pain at baseline, and 3 months post-intervention. Participants in the intervention group attended a focus group immediately following the completion of the programme and the control group participated in individual interviews. RESULTS Seven of ten individuals recruited participated in the study. Majority of participants had Rheumatoid Arthritis and were working full-time. The mean age of intervention participants was 53 ± 10.4 and 56.5 ± 3.7 for the controls. All participants in the intervention group had 100% attendance, completed all study measures and activities. Participants had positive comments about the programme format, content, and delivery. Improvements were observed in most measures at follow up. CONCLUSION Results suggest that an online programme to improve work ability was feasible and acceptable to individuals with inflammatory arthritis. The online delivery format was favoured over attending a centre-based programme. The findings support a definitive intervention trial of online FAME-W.
Collapse
Affiliation(s)
- Shalaleh Karkon
- Discipline of Occupational Therapy, Trinity Centre for Health Sciences, St James' Hospital, Dublin, Ireland
| | - Finbar O'Shea
- Rheumatology Department, St James' Hospital, Dublin, Ireland
| | - Michelle Doran
- Rheumatology Department, St James' Hospital, Dublin, Ireland
| | - Hazel McCormack
- Occupational Therapy Department, St James' Hospital, Dublin, Ireland
| | - Deirdre Connolly
- Discipline of Occupational Therapy, Trinity Centre for Health Sciences, St James' Hospital, Dublin, Ireland
| |
Collapse
|
7
|
Duff E, Gilhooley E, O'Shea F, Wynne B. The association between subacute cutaneous lupus erythematosus and malignancy. J Eur Acad Dermatol Venereol 2023; 37:e804-e805. [PMID: 36785970 DOI: 10.1111/jdv.18959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2023] [Accepted: 02/08/2023] [Indexed: 02/15/2023]
Affiliation(s)
- E Duff
- Department of Dermatology, St James's Hospital, Dublin, Ireland
| | - E Gilhooley
- Department of Dermatology, St James's Hospital, Dublin, Ireland
| | - F O'Shea
- Department of Rheumatology, St James's Hospital, Dublin, Ireland
| | - B Wynne
- Department of Dermatology, St James's Hospital, Dublin, Ireland
| |
Collapse
|
8
|
Kenyon M, Maguire S, Rueda Pujol A, O'Shea F, McManus R. The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease. Rheumatol Int 2022; 42:2085-2095. [PMID: 35939079 PMCID: PMC9548471 DOI: 10.1007/s00296-022-05174-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Accepted: 07/20/2022] [Indexed: 11/25/2022]
Abstract
Ankylosing spondylitis (AS) is a seronegative, chronic inflammatory arthritis with high genetic burden. A strong association with HLA-B27 has long been established, but to date its contribution to disease aetiology remains unresolved. Recent insights through genome wide studies reveal an increasing array of immunogenetic risk variants extraneous to the HLA complex in AS cohorts. These genetic traits build a complex profile of disease causality, highlighting several molecular pathways associated with the condition. This and other evidence strongly implicates T-cell-driven pathology, revolving around the T helper 17 cell subset as an important contributor to disease. This prominence of the T helper 17 cell subset has presented the opportunity for therapeutic intervention through inhibition of interleukins 17 and 23 which drive T helper 17 activity. While targeting of interleukin 17 has proven effective, this success has not been replicated with interleukin 23 inhibition in AS patients. Evidence points to significant genetic diversity between AS patients which may, in part, explain the observed refractoriness among a proportion of patients. In this review we discuss the impact of genetics on our understanding of AS and its relationship with closely linked pathologies. We further explore how genetics can be used in the development of therapeutics and as a tool to assist in the diagnosis and management of patients. This evidence indicates that genetic profiling should play a role in the clinician’s choice of therapy as part of a precision medicine strategy towards disease management.
Collapse
Affiliation(s)
- Marcus Kenyon
- Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
| | - Sinead Maguire
- Department of Rheumatology, St James' Hospital, Dublin, Ireland
| | - Anna Rueda Pujol
- Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Dublin, Ireland
| | - Ross McManus
- Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
9
|
Maguire S, Wilson F, Gallagher P, O'Shea F. Central Obesity in Axial Spondyloarthritis: The Missing Link to Understanding Worse Outcomes in Women? J Rheumatol 2022; 49:577-584. [PMID: 35232810 DOI: 10.3899/jrheum.211062] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/04/2022] [Indexed: 06/14/2023]
Abstract
OBJECTIVE To determine (1) the prevalence of central obesity in axial spondyloarthritis (axSpA) and its effect on disease-related outcomes and (2) how this differs between sexes. METHODS Data were extracted from the Ankylosing Spondylitis Registry of Ireland. Patients with physical measurements for the calculation of anthropometric measures were included. BMI and waist-to-hip ratio (WHR) were used to compare classifications of obesity. Comparison analyses based on sex and central obesity were carried out. Multivariate analysis examined the effects of these factors on the following patient-reported outcomes: the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI), the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire, and the Health Assessment Questionnaire (HAQ). RESULTS In total, 753 patients were included in the analysis. Of these patients, 29.6% (n = 223) were classified as obese based on their BMI, and 41.3% (n = 311) were classified as centrally obese according to the WHR. The prevalence of central obesity was significantly higher among women with axSpA compared to men (71.6% vs 29.9%, P < 0.01). Central obesity had a clear effect on patient outcomes, regardless of sex. Presence of central obesity was associated with significantly worse BASFI scores (P < 0.01), HAQ scores (P < 0.01), and ASQoL questionnaire scores (P = 0.01), with a nonsignificant trend toward worse BASDAI scores (P = 0.07). CONCLUSION There was a high prevalence of central obesity as assessed by the WHR in axSpA, most notably among women with axSpA. This modifiable comorbidity was significantly associated with worse quality of life, greater impairment of functional ability, and a trend toward worse disease activity. Regular use of the WHR to screen for central obesity as part of an axSpA assessment would provide an opportunity for prompt identification and intervention for at-risk patients.
Collapse
Affiliation(s)
- Sinead Maguire
- S. Maguire, MB, BAO, BCh, MRCPI, F. O'Shea, MB, BAO, BCh, MRCPI, Department of Rheumatology, St James' Hospital, and School of Medicine, Trinity College Dublin;
| | - Fiona Wilson
- F. Wilson, BSc, MSc (Sports Medicine), PhD, Discipline of Physiotherapy, Trinity College Dublin
| | - Phil Gallagher
- P. Gallagher, RGN, Department of Rheumatology, St. Vincent's Hospital, Dublin, Ireland
| | - Finbar O'Shea
- S. Maguire, MB, BAO, BCh, MRCPI, F. O'Shea, MB, BAO, BCh, MRCPI, Department of Rheumatology, St James' Hospital, and School of Medicine, Trinity College Dublin
| |
Collapse
|
10
|
Maguire S, Wilson F, Gallagher P, O'Shea F. P256 Complications in Pregnancy are Common in Women with Axial Spondyloarthropathy: Data from the Ankylosing Spondylitis Registry of Ireland. Rheumatology (Oxford) 2022. [DOI: 10.1093/rheumatology/keac133.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background/Aims
National registries are excellent data sources to allow analysis of inflammatory arthritis such as axial spondyloarthropathy (axSpA). Our understanding of axSpA has evolved rapidly over time resulting in improved recognition of the disease. Unfortunately for women with axSpA, there are limited data on pregnancy outcomes in this population. To address this issue, data were collected on pregnancy within the Ankylosing Spondylitis Registry of Ireland (ASRI), which is a source of epidemiological data on axSpA in Ireland. The aim of this study was to examine the prevalence of pregnancy and fetal complications in women with axSpA.
Methods
The ASRI records information on baseline demographics, imaging, medications, patient outcomes and comorbidities. For enrolment, all patients must have been diagnosed with axSpA by a rheumatologist and meet the ASAS criteria. Informed consent was obtained from all patients, with ethical approval obtained from local hospital ethics committees. A dedicated section collects data on pregnancy, fertility and breastfeeding. ASRI outcomes data for women with axSpA were recorded retrospectively.
Results
At the time of analysis, 220 women were enrolled in the ASRI, representing 24.3% of the total population of the registry. Mean age of women was 43.9 years, with a mean disease duration of 18 years and mean delay to diagnosis of 7.86 years. 68.6% (151) had radiographic sacroiliitis, while 49.5% (109) had sacroiliitis on MRI. Mean scores for women in the ASRI were: BASDAI 4.6, BASFI 3.82, BASMI, HAQ 0.6, and ASQoL 7.65. Data on pregnancy were available in 76 women, with 61 women reporting a total of 210 pregnancies resulting in 166 live births. Of these pregnancies, 58.1% (122) were uncomplicated and 41.9% (88) were complicated, with 11.4% (24) of pregnancies encountering multiple complications. The frequency of miscarriage was high, affecting 20.5% (43) of pregnancies overall in 37.7% (23) of women with a history of pregnancy. Of the pregnancies resulting in live births, the most common pregnancy complication was caesarean section in 10.8% (18) followed by preterm delivery in 11.4% (15), while the most common fetal complication was NICU admission in 11.4% (19). Only four women (5.3%) reported difficulty conceiving and the need for fertility specialist referral, but none underwent assisted reproductive therapy. Prevalence of breastfeeding was low, reported in only 33.7% (56) of live births.
Conclusion
Data from the ASRI indicates a high frequency of pregnancy and fetal complications in women with axSpA. These results represent a preliminary analysis of pregnancy outcomes in axSpA pregnancies collected via a large national registry. Ongoing data collection will allow comparison to national averages. This provides much needed insight into the impact of axSpA on pregnancy, which can be used to improve monitoring and management of women with axSpA during their pregnancies.
Disclosure
S. Maguire: Grants/research support; Recipient of the Gilead Inflammation Fellowship. F. Wilson: None. P. Gallagher: None. F. O'Shea: None.
Collapse
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, Dublin, IRELAND
- School of Medicine, Trinity College Dublin, Dublin, IRELAND
| | - Fiona Wilson
- Discipline of Physiotherapy, Trinity College Dublin, Dublin, IRELAND
| | - Phil Gallagher
- Department of Rheumatology, St Vincent's Hospital, Dublin, IRELAND
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Dublin, IRELAND
- School of Medicine, Trinity College Dublin, Dublin, IRELAND
| |
Collapse
|
11
|
Maguire S, Gallagher P, O'Shea F. The negative impact of undiagnosed depression in axial spondyloarthropathy. Clin Exp Rheumatol 2022; 40:669-670. [DOI: 10.55563/clinexprheumatol/d6518k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Accepted: 10/06/2021] [Indexed: 11/13/2022]
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, and School of Medicine, Trinity College Dublin, Ireland.
| | - Phil Gallagher
- Department of Rheumatology, St Vincent's Hospital, Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, and School of Medicine, Trinity College Dublin, Ireland
| |
Collapse
|
12
|
Maguire S, Wilson F, Gallagher P, Mohamed MMS, Maher S, O'Shea F. What to Expect when Women with Axial Spondyloarthritis are Expecting: Prevalence of Complications of Pregnancies in Women with Axial Spondyloarthritis. Semin Arthritis Rheum 2022; 54:151993. [DOI: 10.1016/j.semarthrit.2022.151993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Revised: 03/03/2022] [Accepted: 03/08/2022] [Indexed: 11/29/2022]
|
13
|
Maguire S, Fitzgerald G, Gallagher P, O'Shea F. Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI). Rheumatol Int 2022; 42:831-838. [PMID: 35088133 DOI: 10.1007/s00296-021-05067-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 12/06/2021] [Indexed: 10/19/2022]
Abstract
The Ankylosing Spondylitis Registry of Ireland (ASRI) captures both radiographic and non-radiographic axial spondyloarthritis (axSpA) in a large, well characterised cohort. This is a valuable resource for studies in therapeutics and burden of disease, following a period of rapid change in the field of axSpA. This study aims to perform a focused analysis on patient outcomes and pattern of medication usage in axSpA. This is a cross-sectional study of registry data on 885 patients with confirmed axSpA as per the ASAS criteria for axSpA, as diagnosed by a Rheumatologist. Analysis was performed using IBM SPSS version 26. Patients were analysed on the basis of treatment categorised as: no medication, NSAIDs, biologics or combination therapy. Statistical significance was indicated by p value of < 0.05. Currently 885 patients are enrolled in the ASRI, made up of 72.5% (642) males and 26.9% (238) females. The majority of the cohort was categorized as radiographic axSpA 78.3% (693), with 21.7% (192) meeting criteria for non-radiographic disease. Overall 40.6% (359) reported at least one comorbidity. Older age was associated with no medications compared to those on biologic therapy (50.3 vs 45, p = 0.01). Lower levels of disease activity and higher quality of life were noted in those on biologics as compared to NSAIDs alone. This analysis provides detailed epidemiological data on axSpA from a large national registry. These results detail significant differences in prescribing patterns and impact on patient outcomes in axSpA. Ongoing development of registries provides a valuable insight into the real-world effects of axSpA.
Collapse
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, Dublin, Ireland. .,School of Medicine, Trinity College, Dublin, Ireland.
| | - Gillian Fitzgerald
- School of Medicine, National University of Ireland Galway, Galway, Ireland.,Department of Rheumatology, Galway University Hospital, Galway, Ireland
| | - Phil Gallagher
- Department of Rheumatology, St Vincent's Hospital, Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Dublin, Ireland.,School of Medicine, Trinity College, Dublin, Ireland
| |
Collapse
|
14
|
Maguire S, O'Shea F. The Same But Different? An Analysis of Late-Onset Axial Spondyloarthropathy. J Clin Rheumatol 2022; 28:e294-e296. [PMID: 33394833 DOI: 10.1097/rhu.0000000000001700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Sinead Maguire
- From the Department of Rheumatology, St James' Hospital, Dublin, Ireland
| | | |
Collapse
|
15
|
Maguire S, Wilson F, Gallagher P, O'Shea F. The toll of unemployment in axial spondyloarthropathy: high prevalence and negative impact on outcomes captured in a national registry. Scand J Rheumatol 2021; 51:300-303. [PMID: 34788188 DOI: 10.1080/03009742.2021.1992861] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
OBJECTIVE Axial spondyloarthropathy (axSpA) is an inflammatory arthritis of the axial skeleton. Persistent disease activity can result in significant disability and affect the ability to maintain employment. This study aimed to determine the prevalence of unemployment in axSpA and the impact on patient outcomes. METHOD Data from the Ankylosing Spondylitis Registry of Ireland (ASRI) were cleaned, and information on employment, demographics, and disease characteristics was extracted. Patients were analysed on the basis of employment and categorized as employed or unemployed. RESULTS Of the 759 participants included in the analysis, 23.5% (178) were unemployed, higher than national averages of 6.2-13.1% during the study period. Unemployed participants reported significantly worse Bath Ankylosing Spondylitis Disease Activity Index (BASDAI; 5.1 vs 3.6), Metrology Index (BASMI; 4.8 vs 3.4), Functional Index (BASFI; 5.2 vs 3.0), Health Assessment Questionnaire (HAQ; 0.82 vs 0.40), and Ankylosing Spondylitis Quality of Life (ASQoL; 9.4 vs 5.4) scores compared to employed (all p < 0.01). Male gender (odds ratio, 95% confidence interval: 2.65, 1.46-4.83), worse BASMI (1.16, 1.02-1.33), and worse HAQ scores (2.18, 1.13-4.19) were significantly associated with unemployment. CONCLUSION The prevalence of unemployment in axSpA patients is higher than in the general population, and is associated with worse quality of life, poorer levels of function, and higher levels of disease activity. Predictors of unemployment in axSpA were male gender, worse spinal mobility, and poorer level of function. Recognition of patients at risk of unemployment will improve opportunities for intervention and maintain participation in the workforce.
Collapse
Affiliation(s)
- S Maguire
- Department of Rheumatology, St James' Hospital, Dublin, Ireland.,School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - F Wilson
- Discipline of Physiotherapy, Trinity College Dublin, Dublin, Ireland
| | - P Gallagher
- Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland
| | - F O'Shea
- Department of Rheumatology, St James' Hospital, Dublin, Ireland.,School of Medicine, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
16
|
Maguire S, Fitzgerald G, O'Shea F. Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J Rheumatol 2021; 48:1890. [PMID: 34470800 DOI: 10.3899/jrheum.210469] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, Dublin; .,School of Medicine, Trinity College Dublin, Dublin
| | - Gillian Fitzgerald
- Department of Rheumatology, Galway University Hospitals, Galway, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Dublin.,School of Medicine, Trinity College Dublin, Dublin
| |
Collapse
|
17
|
Maguire S, Gallagher P, O'Shea F. The negative impact of depression in women with Axial Spondyloarthropathy. Joint Bone Spine 2021; 89:105261. [PMID: 34481944 DOI: 10.1016/j.jbspin.2021.105261] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Accepted: 08/16/2021] [Indexed: 12/27/2022]
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, James' Street, Dublin 8, Ireland; School of Medicine, Trinity College, Dublin, Ireland.
| | - Phil Gallagher
- Department of Rheumatology, St Vincent's Hospital, Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, James' Street, Dublin 8, Ireland; School of Medicine, Trinity College, Dublin, Ireland
| |
Collapse
|
18
|
Turk M, Murray K, Alammari Y, Gorman A, Young F, Gallagher P, Saber T, Freeman L, Maguire S, O'Shea F, Fearon U, Veale D. The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis. RMD Open 2021; 7:rmdopen-2020-001510. [PMID: 33875561 PMCID: PMC8057575 DOI: 10.1136/rmdopen-2020-001510] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2020] [Revised: 03/15/2021] [Accepted: 03/22/2021] [Indexed: 11/26/2022] Open
Abstract
Objective The role of alcohol in inflammatory disease remains debated. This study explores the relationship between alcohol and disease activity in patients with inflammatory arthritis. Methods Patients attending a rheumatology clinic between 2010 and 2020 were prospectively followed. Information on demographics, alcohol use, smoking habits and disease outcome measures were collected from these patients. Statistical analysis included univariate and multivariate linear and binary logistic regressions, Mann-Whitney U tests and one-way analysis of variance with Tukey’s honest significant difference (HSD) test. Results Of the 979 analysed patients, 62% had rheumatoid arthritis (RA), 26.7% had psoriatic arthritis (PsA) and 11.2% had ankylosing spondylitis. Mean DAS28-CRP (Disease Activity Score 28 - C-reactive protein) in RA and PsA at 1 year was 2.96±1.39, and 64.2% of patients were in remission (DAS28-CRP ≤2.6 or BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) ≤4). Both male gender and risky drinking (>15 units of weekly alcohol) were significantly associated with remission. Compared with women, men had an OR of 1.8 (1.1, 2.5) (p=0.034) for any alcohol consumption and 6.9 (4.7, 9.1) (p=0.001) for drinking at least 15 weekly drinks. When adjusted for gender, there was no association between alcohol and disease activity. Yet, when adjusted for alcohol consumption, gender still significantly influenced disease activity. Conclusion While it may appear that alcohol is linked to remission in inflammatory arthritis, when adjusted for gender, it is not. Men with inflammatory arthritis drink significantly more than women and have less severe disease activity.
Collapse
Affiliation(s)
- Matthew Turk
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | - Kieran Murray
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | - Yousef Alammari
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | - Aine Gorman
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | - Francis Young
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | - Phil Gallagher
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | - Tajvur Saber
- Rheumatology, Lady Reading Hospital, Peshawar, Pakistan
| | - Lorna Freeman
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| | | | | | - Ursula Fearon
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland.,Trinity College Dublin, Dublin, Ireland
| | - Douglas Veale
- The Centre for Arthritis and Rheumatic Disease, St Vincent's University Hospital, Dublin, Ireland
| |
Collapse
|
19
|
Maguire S, O'Dwyer T, Mockler D, O'Shea F, Wilson F. Corrigendum to Pregnancy in Axial Spondyloarthropathy: A Systematic Review & Meta-Analysis Seminars Arthritis Rheum 50 (2020):1269-1279. Semin Arthritis Rheum 2021; 51:1389. [PMID: 34134894 DOI: 10.1016/j.semarthrit.2021.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, Dublin, Ireland.
| | | | - David Mockler
- John Stearne Medical Library, Trinity College Dublin, Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Dublin, Ireland
| | - Fiona Wilson
- Discipline of Physiotherapy, Trinity College, Dublin, Ireland
| |
Collapse
|
20
|
Abstract
Abstract
Background/Aims
Research has shown that females with axial spondyloarthritis (axSpA) score worse on patient reported outcomes (PROs) than males. However, this does not always correlate to worse clinical findings. The purpose of this study was to understand why women with axSpA have worse BASDAI scores than men, by examining how both genders score across the components of the BASDAI. The Ankylosing Spondylitis Registry of Ireland (ARSI) is a national registry on patients with axSpA in Ireland and a source of epidemiological data.
Methods
Analysis of the ASRI was preformed using IBM SPSS version 26. Patients were analysed on the basis of gender. Comparison of baseline characteristics and mean BASMI, BASFI, HAQ and ASQoL were tested for significance using an independent two tailed t-test and a Mann Whitney U test. Mean total BASDAI score and mean score for each component of the BASDAI were compared and tested for significance with the same statistical tests. A chi-squared test for independence was used to determine significance in variation of HLA-B27 status and radiographic findings.
Results
A total of 857 patients were included in the analysis. Patient population was 24.9% (213) female and 75.1% (644) male with a mean age of 45.9 years and mean disease duration of 19.4 years (means: BASDAI 4.02, BASMI 4, BASFI 3.67, HAQ 0.53, ASQoL 6.48). Females had worse BASDAI(4.6 vs 3.83, p < 0.01), HAQ(0.6 vs 0.51, p = 0.03) and ASQoL scores (7.62 vs 6.12, p < 0.01) than males. BASFI scores were worse in females which did not reach significance (3.89 vs 3.63, p = 0.26). However, females had significantly better BASMI scores than males (3.51 vs 4.16, p < 0.01). Within the BASDAI, females scored significantly worse than males across all components (Fatigue: 5.56 vs 4.51, p < 0.01; Spinal pain: 5.51 vs 4.63, p < 0.01; Other pain: 3.82 vs 3.19, p = 0.01; Discomfort: 4.05 vs 3.29, p < 0.01; EMS: 4.55 vs 3.94, p = 0.01), however duration of EMS did not reach significance (3.54 vs 3.12, p = 0.07)(table 1). Within the BASDAI, females recorded highest mean scores for fatigue (5.56), while males recorded highest mean scores for spinal pain(4.63). Lowest mean scores for both genders was for EMS duration (3.54 vs 3.12). Ranking of the BASDAI components by mean scores show similarity in the ranking of discomfort, EMS, other pain and EMS duration.
Conclusion
AxSpA females have consistently worse PROs but have better spinal mobility than males. Despite females recording worse BASDAI scores than males, the pattern of disease activity manifestation is similar in 4 of the 6 components of the BASDAI. However, fatigue is the most problematic symptom in females with active axSpA while spinal pain is the most problematic symptom for males. This variation by gender should be kept in consideration when evaluating a patient with suspected active axSpA.
Disclosure
S. Maguire: None. P. Gallagher: None. F. O'Shea: None.
Collapse
|
21
|
Maguire S, O'Shea F. P180 Undiagnosed depression in axial spondyloarthropathy negatively affects disease activity and quality of life. Rheumatology (Oxford) 2021. [DOI: 10.1093/rheumatology/keab247.175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background/Aims
Previous research in axial spondyloarthropathy (axSpA) has shown this population to have a high prevalence of depression. This co-morbidity has been previously shown to impact disease activity in patients with rheumatic disease. The purpose of this study was to screen for signs of depression using two validated tools, the Patient Health Questionaire-9 (PHQ-9) and the Hospital Anxiety and Depression Scale for depression (HADs-D) in axSpA patients.
Methods
AxSpA patients attending the rheumatology department in St James’ Hospital between February and October 2020 were invited to take a self-administered survey which included the PHQ-9 and the HADs-D. Scores from the HADs-D yielded a numerical result which was then categorised as normal, borderline or abnormal. PHQ-9 numerical results were categorised as normal, mild, moderate, moderate/severe or severe. Patients with a known diagnosis of depression were excluded. In addition to baseline demographics, patient reported outcomes were also recorded. Data analysis was performed using IBM SPSS version 26. Continuous variables were recorded as means, categorical variables as frequencies with percentages. A one-way analysis of variance analysis (ANOVA) determined significance of variation in outcomes between patient outcomes as determined by the HADs-D and PHQ-9. A p-value of < 0.05 was deemed significant. Consent was obtained prior to participation. Approval was received from the St James’/Tallaght Hospital Joint Ethics Committee.
Results
In total 71 axSpA patients took part in the survey. The population was 70.4% (50) males and 29.5% (21) female, with an average age 47.9 years and mean disease duration 19.7 years (mean outcomes: BASDAI 4.08, BASFI 3.62, BASMI 3.54, ASQoL 6.79). Overall, 7 (9.9%) participants recorded abnormal HADs D scores, while 17 (23.9%) recorded moderate to severe PHQ-9 scores indicative of underlying depression. AxSpA females had higher mean HADs-D scores (7.5 vs 4.8, p = 0.01) than males, with abnormal scores in 19% (4) of females and 6% (3) of males. No significant differences were found in PHQ-9 scores between genders. Analysis revealed significantly worse BASDAI (6.27 vs 3.42, p < 0.01) and AQoL scores (12.57 vs 5.26, p < 0.01) in axSpA patients with abnormal compared to normal HADs D scores. No significant differences were noted in BASFI, BASMI or baseline demographics. A similar pattern was noted on analysis of PHQ-9 scores, with significantly worse BASDAI (7.9 vs 2.55, p < 0.01), BASFI (8.05 vs 2.33, p < 0.01) and ASQoL (19.5 vs 2.62, p < 0.01) noted in those scoring as severe compared to normal. No significant differences were detected in BASMI scores or baseline demographics.
Conclusion
A high percentage of axSpA patients recorded high HADs D and PHQ-9 scores for undiagnosed depression. These patients had significantly worse disease activity and quality of life as compared to patients with normal scores. Clinicians treating axSpA should consider screening for depression in this population.
Disclosure
S. Maguire: None. F. O'Shea: None.
Collapse
|
22
|
Huang XF, Li Z, De Guzman E, Robinson P, Gensler L, Ward MM, Rahbar MH, Lee M, Weisman MH, Macfarlane GJ, Jones GT, Klingberg E, Forsblad-d'Elia H, McCluskey P, Wakefield D, Coombes JS, Fiatarone Singh MA, Mavros Y, Vlahovich N, Hughes DC, Marzo-Ortega H, Van der Horste-Bruinsma I, O'Shea F, Martin TM, Rosenbaum J, Breban M, Jin ZB, Leo P, Reveille JD, Wordsworth BP, Brown MA. Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci. Invest Ophthalmol Vis Sci 2021; 61:3. [PMID: 32492107 PMCID: PMC7415282 DOI: 10.1167/iovs.61.6.3] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Purpose Acute anterior uveitis (AAU) is a common intraocular inflammatory disease. AAU occurs in 30% to 50% of patients with ankylosing spondylitis (AS), and both conditions are strongly associated with human leukocyte antigen (HLA)-B27, implying a shared etiology. This study aims to apply genomewide association study (GWAS) to characterize the genetic associations of AAU and their relationship to the genetics of AS. Methods We undertook the GWAS analyses in 2752 patients with AS with AAU (cases) and 3836 patients with AS without AAU (controls). There were 7,436,415 single-nucleotide polymorphisms (SNPs) available after SNP microarray genotyping, imputation, and quality-control filtering. Results We identified one locus associated with AAU at genomewide significance: rs9378248 (P = 2.69 × 10−8, odds ratio [OR] = 0.78), lying close to HLA-B. Suggestive association was observed at 11 additional loci, including previously reported AS loci ERAP1 (rs27529, P = 2.19 × 10−7, OR = 1.22) and NOS2 (rs2274894, P = 8.22 × 10−7, OR = 0.83). Multiple novel suggestive associations were also identified, including MERTK (rs10171979, P = 2.56 × 10−6, OR = 1.20), KIFAP3 (rs508063, P = 5.64 × 10−7, OR = 1.20), CLCN7 (rs67412457, P = 1.33 × 10−6, OR = 1.25), ACAA2 (rs9947182, P = 9.70 × 10−7, OR = 1.37), and 5 intergenic loci. The SNP-based heritability is approximately 0.5 for AS alone, and is much higher (approximately 0.7) for AS with AAU. Consistent with the high heritability, a genomewide polygenic risk score shows strong power in identifying individuals at high risk of either AS with AAU or AS alone. Conclusions We report here the first GWAS for AAU and identify new susceptibility loci. Our findings confirm the strong overlap in etiopathogenesis of AAU with AS, and also provide new insights into the genetic basis of AAU.
Collapse
|
23
|
Maguire S, O'Dwyer T, Mockler D, O'Shea F, Wilson F. Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis. Semin Arthritis Rheum 2020; 50:1269-1279. [PMID: 33065422 DOI: 10.1016/j.semarthrit.2020.08.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 08/18/2020] [Accepted: 08/24/2020] [Indexed: 02/09/2023]
Abstract
BACKGROUND Axial spondyloarthropathy (axSpA) is an inflammatory arthritis which affects the sacroiliac joints and the spine. Many females affected are of childbearing age. Studies on effects of pregnancy on axSpA disease activity and medication use have been limited, with divergent conclusions. OBJECTIVE To review literature on axSpA in pregnancy to determine the effect of disease on pregnancy outcomes. METHODS A systematic review of case-control trials, observational studies, cross sectional studies and case series (n>5) on axSpA in pregnancy. EMBASE, Medline (OVID), CINAHL, Maternity and Infant Care (MIDIRS online), and Web of Science were searched for keywords. Two reviewers reviewed articles to determine suitability for inclusion. The Newcastle Ottawa Scale was used to assess risk of bias. Data extraction was performed using a standardized template to streamline data to allow comparison and meta-analysis. RESULTS Search strategy returned 884 records, 130 full text articles were assessed for eligibility. Eighteen studies with a total of 3,166 axSpA participants were eligible for inclusion. There was an increased prevalence of pre-eclampsia (OR 1.3, 95% CI 0.92-1.82) and IUGR (OR 1.17, 95% CI 0.26-5.17) and a statistically significant increase in cesarean sections (OR 1.85, 95% CI 1.46-2.30) in axSpA females, with an especially high prevalence of elective cesarean sections (OR 2.26, 95% CI 1.74, 2.93). There was a trend towards increased prevalence of fetal complications in axSpA pregnancies (LBW OR 1.47, 95% CI 0.98-2.21; SGA OR1.66, 95% CI 0.93-2.95; congenital abnormalities OR 1.34, 95% CI0.63-1.24; NICU admissions OR 1.55, 95% CI 0.96-2.51) which did not reach significance. CONCLUSION AxSpA females have an increased prevalence of cesarean sections compared to the general population. There is a trend towards increased prevalence of pre-eclampsia, IUGR and certain fetal complications. Ongoing development of national registries could help to better understand axSpA in pregnancy.
Collapse
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, James' Street, Dublin, Ireland.
| | | | - David Mockler
- John Stearne Medical Library, Trinity College Dublin, Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, James' Street, Dublin, Ireland
| | - Fiona Wilson
- Discipline of Physiotherapy, Trinity College, Dublin, Ireland
| |
Collapse
|
24
|
Maguire S, O'Shea F. Social isolation due to the COVID-19 pandemic has led to worse outcomes in females with inflammatory arthritis. Ir J Med Sci 2020; 190:33-38. [PMID: 32656691 PMCID: PMC7354357 DOI: 10.1007/s11845-020-02307-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Accepted: 07/05/2020] [Indexed: 11/30/2022]
Abstract
Background Prolonged social isolation as a result of the COVID-19 global pandemic has been a source of considerable psychological distress for many people. This can manifest in many ways and if left undetected can impact negatively on general health. It is essential to understand the impact of these conditions on inflammatory arthritis (IA) patients, especially axial spondyloarthropathy (axSpA). Aim To capture the level of psychological distress for patients with IA following prolonged social isolation. Methods A survey was sent out to patients with a confirmed diagnosis of IA. This captured changes in sleep, mood, disease activity, employment and general health since the beginning of the social isolation period. A PHQ-4 (Patient Health Questionnaire) was included to determine level of psychological distress. Results Females with IA reported significantly higher rates of decline in general health (40% vs 16%, p = 0.01), mood disturbance (43.4% vs 26%, p = 0.03) and increased disease activity (50% vs 16%, p = 0.01) compared to males. Evaluating the mean PHQ-4 scores, no significant difference was noted between genders (4.80 vs 3.44, p = 0.10). However, females demonstrated a non-significant trend toward increased rates of moderate to severe psychological distress (40% vs 30%, p = 0.13). Subanalysis of patients with axSpA found high rates of moderate to severe distress in both genders. Conclusions Females with IA reported significantly higher rates of decline in general health, mood disturbance and increased disease activity during the period of social isolation. This was reflected in a trend towards greater levels of psychological distress.
Collapse
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, Dublin, Ireland.
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Dublin, Ireland
| |
Collapse
|
25
|
Abstract
Axial spondyloathritis (axSpA) treatment with biologic DMARDs was previously focused around anti-TNF agents. Significant advances in research have led to new therapeutic options, such as secukinumab, an IL-17 inhibitor, which has been approved for the treatment of axSpA. Two other biologic agents that are already licensed for rheumatoid and psoriatic arthritis, tofacitinib and ixekizumab, have demonstrated improved outcomes in axSpA. Several newer agents have been developed to inhibit IL-17, IL-23, and JAK. Early trials are promising; however, further research is needed. Rapid expansion of therapies available to treat axSpA could lead to improved disease control and decreased disease burden.
Collapse
Affiliation(s)
- Sinead Maguire
- Department of Rheumatology, St James' Hospital, Ushers Quay, Dublin D08 NHY1, Ireland
| | - Raj Sengupta
- Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Combe Park, Bath BA1 3NG, UK
| | - Finbar O'Shea
- Department of Rheumatology, St James' Hospital, Ushers Quay, Dublin D08 NHY1, Ireland.
| |
Collapse
|
26
|
Fitzgerald G, Anachebe T, McCarroll K, O'Shea F. Measuring bone density in axial spondyloarthropathy: Time to turn things on their side? Int J Rheum Dis 2020; 23:358-366. [PMID: 31909570 DOI: 10.1111/1756-185x.13765] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Revised: 11/15/2019] [Accepted: 11/16/2019] [Indexed: 01/05/2023]
Abstract
AIM Osteoporosis in axial spondyloarthropathy (axSpA) is difficult to accurately diagnose due to osteoproliferation of the spine interfering with conventional (anteroposterior, AP) dual-energy X-ray absorptiometry (DXA). This study compares AP and lateral projections of DXA when assessing bone mineral density (BMD) of the spine and investigates the impact of osteoproliferation on AP DXA. METHOD In this cross-sectional study, structured standardized assessments collected demographic, clinical, laboratory and radiographic data. DXA assessed BMD of the spine using PA and lateral projections. Hip BMD was assessed in the usual manner. World Health Organization (WHO) criteria assessed prevalence of low BMD. Incorporating lateral DXA in the bone health assessment of axSpA was investigated. SPSS was used for statistical analysis. RESULTS A total of 100 patients had paired AP and lateral DXA studies: 78% were male, mean (SD) age 52 (12) years. BMD of the spine measured by AP projection was significantly higher than BMD measured by lateral projection (mean difference 0.34 g/cm2 , 95% CI 0.30-0.37). More patients had low BMD with lateral compared to AP projection (47% vs 16%, P = .01). At the hip, 34% of patients had low BMD. Disease duration, body mass index and radiographic severity independently predicted a difference between AP and lateral measurements of the spine. CONCLUSION Lateral DXA of the spine is unaffected by osteoproliferation of the spine in axSpA and detects significantly more cases of low BMD than conventional AP DXA. Lateral DXA should be included in BMD assessment of patients with axSpA.
Collapse
Affiliation(s)
- Gillian Fitzgerald
- School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.,Department of Rheumatology, St. James's Hospital, Dublin, Ireland
| | | | - Kevin McCarroll
- Department of Medicine for the Elderly, St. James's Hospital, Dublin, Ireland
| | - Finbar O'Shea
- School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.,Department of Rheumatology, St. James's Hospital, Dublin, Ireland
| |
Collapse
|
27
|
McCormack RC, O'Shea F, Doran M, Connolly D. Impact of a fatigue management in work programme on meeting work demands of individuals with rheumatic diseases: A pilot study. Musculoskeletal Care 2018; 16:398-404. [PMID: 29575485 DOI: 10.1002/msc.1237] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Revised: 01/17/2018] [Accepted: 01/19/2018] [Indexed: 06/08/2023]
Abstract
INTRODUCTION Work disability and job loss are serious consequences of rheumatic diseases (RDs), and fatigue is a symptom of RDs commonly reported to have an impact on work performance. A FAtigue ManagEment in Work (FAME-W) programme was developed to facilitate the self-management of fatigue in work. The present pilot study explored if FAME-W could facilitate individuals with RDs to manage fatigue in work and improve their ability to meet work demands. METHODS Twenty-seven individuals with a variety of rheumatic diagnoses completed a 4-week, 2-h occupational therapy-led self-management programme. Each week focused on fatigue-related topics, including fatigue and activity management, pain management and joint protection, mental well-being, effective communication with employers and work colleagues, and employment legislation. Individual workplace ergonomic assessments were also offered. Study measures (work function, fatigue, pain, mood and self-efficacy) were completed prior to starting FAME-W, immediately post-intervention and 12 weeks post-intervention. RESULTS Participants (56% male) had a mean age of 43 years. No significant improvements were observed immediately post-programme. However, at the 12-week follow-up, significant improvements were reported in meeting work demands (scheduling [p = 0.046], output [p = 0.002], physical [p = 0.003], mental [p = 0.016]), fatigue [p = 0.001], pain [p = 0.01], anxiety [p = 0.001], depression [p < 0.001], self-efficacy [p < 0.001] and Arthritis Impact Measurement Scales 2-Short Form (physical: p = 0.005; symptoms: p = 0.010; affect: p = 0.010; social: p = 0.001). CONCLUSIONS Significant improvements were reported in participants' ability to meet various demands of their work 3 months post-FAME-W. These findings suggest that FAME-W has the potential to assist individuals with RDs to meet the demands of their work, although further research is required to test the effectiveness of this intervention.
Collapse
Affiliation(s)
- Róisín C McCormack
- Discipline of Occupational Therapy, Trinity Centre for Health Sciences, St James' Hospital, Dublin, Ireland
| | - Finbar O'Shea
- Rheumatology Department, St James' Hospital, Dublin, Ireland
| | - Michele Doran
- Rheumatology Department, St James' Hospital, Dublin, Ireland
| | - Deirdre Connolly
- Discipline of Occupational Therapy, Trinity Centre for Health Sciences, St. James' Hospital, Dublin, Ireland
| |
Collapse
|
28
|
O'Shea F, Taylor PC, Dickie G, Yaworsky A, Banderas B, Kachroo S. Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach. Rheumatol Ther 2018; 5:87-98. [PMID: 29616498 DOI: 10.1007/s40744-018-0107-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2018] [Indexed: 11/25/2022] Open
Abstract
INTRODUCTION To establish clinical consensus on important and relevant quality-of-care (QoC) attributes in rheumatic disease (RD) treatment that may improve treatment outcomes and guide best practices. METHODS Twenty-three QoC attributes were identified in a literature review. Fifteen European-based clinicians were selected based on their contributions to RD guidelines, publications, and patient care. A three-round (an interview round and two web-based rounds) modified Delphi panel was conducted to reach consensus and finalize a QoC attribute list. RESULTS In round 1 (clinician interviews), clinicians reported 52 unique QoC attributes across 14 themes, with the greatest number of attributes reported in the "treatment goals" (n = 7) and "remote monitoring" (n = 7) themes. During rounds 2 and 3, the critically important QoC attributes most frequently reported were access to care/treatment (n = 14, 93.3%), safety of treatment (round 2 n = 14, 93.3%, round 3 n = 13, 86.7%), and access to clinicians and specialists (round 2: n = 13, 86.7%, round 3: n = 14, 93.3%). The final list contained 53 QoC attributes. CONCLUSION The study demonstrates consensus across several themes of QoC. Quality of care is a complex, multidimensional, and fluid concept that can be improved by ensuring patients have access to care, open communication between patients and clinicians, and the use of novel strategies, such as remote monitoring. Utilization of the attribute list can potentially improve the lives of patients, provide clinicians with tools to provide greater QoC, and improve the healthcare system as a whole. FUNDING Merck & Co., Inc.
Collapse
Affiliation(s)
| | - Peter C Taylor
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK
| | | | | | | | - Sumesh Kachroo
- Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA
| |
Collapse
|
29
|
Flynn A, Gilhooley E, O'Shea F, Wynne B. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus. Clin Rheumatol 2018; 37:817-818. [PMID: 29392510 DOI: 10.1007/s10067-018-3999-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2017] [Revised: 01/15/2018] [Accepted: 01/23/2018] [Indexed: 11/30/2022]
Abstract
The American College of Rheumatology (ACR) classification criteria for lupus and Systemic Lupus International Collaborating Clinics (SLICC) criteria are designed to classify disease. However, they have become widely used as diagnostic criteria in clinical situations. Patients may be labelled as systemic lupus erythematosus (SLE) in their medical records, when in fact they have cutaneous lupus erythematosus (CLE) without systemic symptoms. We sought to investigate how many of our cutaneous lupus patients attending a dermatology lupus clinic were mislabelled as either CLE or SLE using the ACR and SLICC criteria. Thirty-six patients with biopsy-proven cutaneous lupus were identified. Fourteen (39%) of the patients were labelled as 'SLE' in their medical notes, either by dermatology or another medical team. Of these 14 patients, 12 (86%) fulfilled the ACR and SLICC criteria; however, two (14%) did not meet the criteria for SLE. Of the remaining 22 patients who were not labelled as having SLE, four (18%) met both the SLICC and ACR criteria, one (5%) met the ACR criteria and one (5%) met the SLICC criteria. These patients had a history of discoid or subacute lupus, with very few systemic symptoms. They met the criteria for SLE primarily on their cutaneous signs and positive serology. It is important to screen patients with CLE routinely for SLE. Although the ACR and SLICC criteria can be helpful as they have a high sensitivity for systemic lupus, their use needs to be paired with the clinical context and patient evolution. We found patients were labelled as SLE when in fact they had no evidence of systemic involvement, as well as patients labelled as cutaneous lupus who fulfilled the criteria for SLE, although unlikely having any systemic involvement. It is important to correctly identify patients as 'cutaneous lupus' or 'systemic lupus erythematosus' and documentation in clinical notes should be accurate to avoid confusion and allow appropriate treatment.
Collapse
Affiliation(s)
- Aoibheann Flynn
- Dermatology Department, St. James's Hospital, Dublin, Ireland.
| | | | - Finbar O'Shea
- Rheumatology Department, St. James's Hospital, Dublin, Ireland
| | - Bairbre Wynne
- Dermatology Department, St. James's Hospital, Dublin, Ireland
| |
Collapse
|
30
|
O'Dwyer T, Monaghan A, Moran J, O'Shea F, Wilson F. Behaviour change intervention increases physical activity, spinal mobility and quality of life in adults with ankylosing spondylitis: a randomised trial. J Physiother 2017; 63:30-39. [PMID: 27989730 DOI: 10.1016/j.jphys.2016.11.009] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2016] [Revised: 05/23/2016] [Accepted: 11/22/2016] [Indexed: 01/24/2023] Open
Abstract
QUESTIONS Does a 3-month behaviour change intervention targeting physical activity (PA) increase habitual physical activity in adults with ankylosing spondylitis (AS)? Does the intervention improve health-related physical fitness, AS-related features, and attitude to exercise? Are any gains maintained over a 3-month follow-up? DESIGN Parallel-group, randomised, controlled trial with concealed allocation, assessor blinding and intention-to-treat analysis. PARTICIPANTS Forty adults with a diagnosis of AS, on stable medication, and without PA-limiting comorbidities. INTERVENTION Over a 3-month period, the experimental group engaged in individually-tailored, semi-structured consultations aiming to motivate and support individuals in participating in PA. The control group continued with usual care. OUTCOME MEASURES The primary outcome was PA measured by accelerometry over 1 week. Secondary outcomes included clinical questionnaires and measures of health-related physical fitness. Measures were taken at baseline, post-intervention, and after a 3-month follow-up period. RESULTS Baseline characteristics were similar across groups, except age and body composition. There were statistically significant, moderate-to-large time-by-group effects in health-enhancing PA (mixed-design ANOVA for overall effect F(2, 76)=14.826, p<0.001), spinal mobility (F(2, 76)=5.691, p<0.005) and quality of life (χ2(2)=8.400, p<0.015) favouring the intervention group; post-intervention improvements were sustained 3 months later. No significant effects were seen in other physical fitness outcomes or on clinical questionnaires. No adverse effects were reported during the study. CONCLUSION Health-enhancing PA, spinal mobility and quality of life were significantly improved after the intervention, and improvements were maintained at 3-month follow-up. TRIAL REGISTRATION NCT02374502. [O'Dwyer T, Monaghan A, Moran J, O'Shea F, Wilson F (2016) Behaviour change intervention increases physical activity, spinal mobility and quality of life in adults with ankylosing spondylitis: a randomised trial.Journal of PhysiotherapyXX: XX-XX].
Collapse
Affiliation(s)
- Tom O'Dwyer
- Discipline of Physiotherapy, Trinity College Dublin, Ireland
| | - Ann Monaghan
- Discipline of Physiotherapy, Trinity College Dublin, Ireland
| | - Jonathan Moran
- Discipline of Physiotherapy, Trinity College Dublin, Ireland
| | - Finbar O'Shea
- Department of Rheumatology, St. James's Hospital, Dublin, Ireland
| | - Fiona Wilson
- Discipline of Physiotherapy, Trinity College Dublin, Ireland
| |
Collapse
|
31
|
O'Dwyer T, Monaghan A, Moran J, Wilson F, O'Shea F. OP0295-HPR Increasing Physical Activity in Ankylosing Spondylitis (Inpact-as): A Randomised Controlled Trial. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
32
|
O'Dwyer T, O'Shea F, Wilson F. THU0636-HPR Significantly Reduced Physical Activity in Adults with Ankylosing Spondylitis: A Cross-Sectional Controlled Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
33
|
O'Dwyer T, Rafferty T, O'Shea F, Gissane C, Wilson F. Physical activity guidelines: is the message getting through to adults with rheumatic conditions? Rheumatology (Oxford) 2014; 53:1812-7. [DOI: 10.1093/rheumatology/keu177] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
34
|
Hugle B, Burgos-Vargas R, Inman RD, O'Shea F, Laxer RM, Stimec J, Whitney-Mahoney K, Duvnjak M, Anderson M, Tse SML. Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol 2014; 32:424-431. [PMID: 24387974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2013] [Accepted: 11/06/2013] [Indexed: 06/03/2023]
Abstract
OBJECTIVES A significant proportion of patients with juvenile spondyloarthritis (JSpA) are refractory to treatment with established medications. The objective of this study was to assess long-term efficacy of treatment with anti-TNF agents in patients with JSpA. METHODS An observational study of 16 patients with JSpA from 3 centres treated with infliximab (n=10) and etanercept (n=6) was performed, with a median follow-up period of 7.2 years. Prospective data was collected according to a standardized protocol. Outcomes examined were TEC, TAJC, markers of inflammation (ESR, CRP), functional assessments (C-HAQ, BASDAI, BASFI), and ongoing requirement for anti-TNF treatment. RESULTS 13/16 patients (83%) had achieved clinical remission 6 months into the treatment. Improvement was sustained over time, with a median TAJC and TEC of 0 at any time point after 6 weeks. 6/16 patients (38%) showed a flare of arthritis after a median of 3.5 years. Two patients with hip disease prior to treatment required an arthroplasty 3 and 8 years post anti-TNF initiation. Patients showed progression of sacroiliitis with median modified New York score of 1 (range 0-3) at time of diagnosis and 3 (range 0-4) at last follow-up (p=0.002). Median BASDAI at last follow up was 1.6, median BASFI 3.1. Two patients developed transient reactions (one generalised, one local); no patient developed other adverse effects during the study. CONCLUSIONS Anti-TNF treatment in JSpA refractory to standard treatment results in good long-term disease control except for pre-existing hip disease. However, radiographic evidence suggests inferior efficacy for control of sacroiliac joint disease.
Collapse
Affiliation(s)
- B Hugle
- Division of Rheumatology, The Hospital for Sick Children, University of Toronto, Canada, and German Center for Paediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Marinelli A, Hemsing E, Dunning M, Xiang D, Weathersby S, O'Shea F, Gadjev I, Hast C, Rosenzweig JB. Generation of coherent broadband photon pulses with a cascaded longitudinal space-charge amplifier. Phys Rev Lett 2013; 110:264802. [PMID: 23848882 DOI: 10.1103/physrevlett.110.264802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2013] [Indexed: 06/02/2023]
Abstract
The longitudinal space-charge amplifier has been recently proposed by Schneidmiller and Yurkov as an alternative to the free-electron laser instability for the generation of intense broadband radiation pulses [Phys. Rev. ST Accel. Beams 13, 110701 (2010)]. In this Letter, we report on the experimental demonstration of a cascaded longitudinal space-charge amplifier at optical wavelengths. Although seeded by electron beam shot noise, the strong compression of the electron beam along the three amplification stages leads to emission of coherent undulator radiation pulses exhibiting a single spectral spike and a single transverse mode. The on-axis gain is estimated to exceed 4 orders of magnitude with respect to spontaneous emission.
Collapse
Affiliation(s)
- A Marinelli
- Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, California 90095, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Marinelli A, Dunning M, Weathersby S, Hemsing E, Xiang D, Andonian G, O'Shea F, Miao J, Hast C, Rosenzweig JB. Single-shot coherent diffraction imaging of microbunched relativistic electron beams for free-electron laser applications. Phys Rev Lett 2013; 110:094802. [PMID: 23496718 DOI: 10.1103/physrevlett.110.094802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2012] [Indexed: 06/01/2023]
Abstract
With the advent of coherent x rays provided by the x-ray free-electron laser (FEL), strong interest has been kindled in sophisticated diffraction imaging techniques. In this Letter, we exploit such techniques for the diagnosis of the density distribution of the intense electron beams typically utilized in an x-ray FEL itself. We have implemented this method by analyzing the far-field coherent transition radiation emitted by an inverse-FEL microbunched electron beam. This analysis utilizes an oversampling phase retrieval method on the transition radiation angular spectrum to reconstruct the transverse spatial distribution of the electron beam. This application of diffraction imaging represents a significant advance in electron beam physics, having critical applications to the diagnosis of high-brightness beams, as well as the collective microbunching instabilities afflicting these systems.
Collapse
Affiliation(s)
- A Marinelli
- Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, California 90095, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
|
38
|
O'Shea F, Salonen D, Inman R. The challenge of early diagnosis in ankylosing spondylitis. J Rheumatol 2007; 34:5-7. [PMID: 17216671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
|
39
|
O'Shea F, Dight A. Should relatives be allowed into the resuscitation room? Nurs Times 1999; 95:30-1. [PMID: 10514711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
|
40
|
Anderson CR, Campbell G, O'Shea F, Payne M. The release of neuronal 5-HT from the intestine of a teleost fish, Platycephalus bassensis. J Auton Nerv Syst 1991; 33:239-46. [PMID: 1717536 DOI: 10.1016/0165-1838(91)90024-w] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The superfused, isolated intestine of a teleost fish which lacks enterochromaffin cells spontaneously released 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA), presumably from enteric neurons. The release of 5-HT, but not 5-HIAA, increased on transmural electrical stimulation. Addition of tetrodotoxin or omission of Ca2+ from the superfusate prevented the increase in 5-HT release on electrical stimulation. Fluoxetine added to the superfusate increased the amount of 5-HT released spontaneously but also prevented the increase in 5-HT release on stimulation. Pretreatment of fish with reserpine markedly reduced tissue levels of 5-HT and 5-HIAA and led to an almost complete loss of the spontaneous release of 5-HT and an elimination of the stimulated release of 5-HT.
Collapse
Affiliation(s)
- C R Anderson
- Department of Zoology, University of Melbourne, Australia
| | | | | | | |
Collapse
|
41
|
Thomas A, Okamoto S, O'Shea F, MacLachlan V, Besanko M, Healy D. Do raised serum luteinizing hormone levels during stimulation for in-vitro fertilization predict outcome? Br J Obstet Gynaecol 1989; 96:1328-32. [PMID: 2611173 DOI: 10.1111/j.1471-0528.1989.tb03232.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Previous reports associating raised LH concentrations with reduced fertilization and pregnancy rates in women undergoing in-vitro fertilization (IVF) have assumed a Gaussian distribution of LH values with IVF treatment. We have determined the serum LH range during ovarian stimulation for IVF with a single regimen of clomiphene citrate/hMG from 102 consecutive IVF conception cycles. The results show a non-Gaussian distribution of LH values. Application of this LH range to a consecutive series of 596 women undergoing IVF treated with this single regimen showed no difference in pregnancy rates, fertilization rates, median number of oocytes fertilized or retrieved when analysed with respect to serum LH concentrations above the 75th or 95th centile for greater than or equal to 3 days of an IVF treatment cycle. We conclude that follicular-phase LH concentrations do not predict IVF fertilization rates or clinical outcome and are not clinically useful in individual patient management.
Collapse
Affiliation(s)
- A Thomas
- Infertility Medical Centre, Richmond, Australia
| | | | | | | | | | | |
Collapse
|
42
|
MacLachlan V, Besanko M, O'Shea F, Wade H, Wood C, Trounson A, Healy DL. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization. N Engl J Med 1989; 320:1233-7. [PMID: 2496310 DOI: 10.1056/nejm198905113201902] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Treatment with clomiphene citrate and human menopausal gonadotropin (HMG) is often used to induce folliculogenesis before in vitro fertilization, but not all women have an adequate response. It has been hypothesized that abnormally high levels of luteinizing hormone (LH) may contribute to the reduced folliculogenesis. We therefore performed a controlled, open trial in which treatment with buserelin, an agonist of luteinizing hormone-releasing hormone citrate and HMG in 44 consecutive women in whom no oocytes or only one had been produced by standard treatment with clomiphene and HMG. Twenty-nine women received buserelin with HMG, and 15 received clomiphene citrate with HMG. The median number of oocytes per patient recovered from those who received buserelin with HMG was 4 (range, 0 to 19), as compared with 0 (range, 0 to 5) in those who received clomiphene citrate with HMG. The fertilization rates of oocytes recovered from both groups of patients were similar (75.8 percent and 76.5 percent, respectively). Fifty-four percent of patients given buserelin with HMG underwent triple-embryo transfer, as compared with 13 percent of those given clomiphene citrate with HMG. Pregnancy (n = 3) occurred only among the patients receiving buserelin with HMG. In the buserelin-HMG group, significantly fewer oocytes were recovered from patients with occult ovarian failure (infertility and elevated follicular-phase levels of follicle-stimulating hormone, with regular menses) (median, 1; range, 0 to 4) than from those with other causes of infertility (median, 8; range, 0 to 19). Our data suggest that, except in women with occult ovarian failure, buserelin and HMG improve embryologic and clinical outcomes in patients with previously unsatisfactory stimulation of the ovaries for in vitro fertilization.
Collapse
Affiliation(s)
- V MacLachlan
- Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia
| | | | | | | | | | | | | |
Collapse
|
43
|
MacLachlan V, Besanko M, Wade H, Morrow L, O'Shea F, Trounson A, Healy D. Luteinizing-hormone-releasing hormone agonist treatment in patients with previously failed folliculogenesis during in vitro fertilization therapy. Ann N Y Acad Sci 1988; 541:60-74. [PMID: 2973764 DOI: 10.1111/j.1749-6632.1988.tb22242.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- V MacLachlan
- Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia
| | | | | | | | | | | | | |
Collapse
|